| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |